About the Chronic Kidney Disease (CKD) Model

The CKD Model is an AI-powered predictive tool to predict the risk of diabetic patients in CKD stage 1 or 2 to deteriorate to stage 3 and above in the next 5 years.

The CKD Model uses advanced machine learning techniques to identify patients at high risk of function decline, allowing clinicians to deploy early intervention methods to avert or delay kidney function deterioration in their patients.

Integrated into the National Electronic Health Records (NEHR), this model supports clinicians nationwide by providing timely, actionable insights that enable early intervention. By helping to delay or prevent kidney failure, the CKD Model contributes to better patient outcomes and more efficient healthcare resource use.

Predicts diabetic patients’ CKD progression risk within five years

Empowers clinicians with updated patient data for informed decision making

Enables early identification to optimise patient treatment

Trained on extensive data for accurate early risk detection

CKD Model at a glance

Opportunity

There are more than 400,000 patients with diabetes in Singapore, and CKD is one of the most common complications. Rising prevalence of diabetes and CKD highlights the need for early detection and intervention. Early detection of patients at risk can prevent progression to kidney failure and reduce healthcare burdens.

Solution

Synapxe developed the CKD Model, an AI-powered predictive tool to estimate the risk of CKD worsening in diabetic patients within 5 years. The model analyses over 177 variables across sociodemographic, diagnostic, laboratory, and medication history categories to predict the risk of CKD progression to stage 3 or above within five years.

Integrated into the National Electronic Health Records (NEHR) for access by clinicians, the model classifies patients into low, high, and extremely high risk to guide clinical decisions and early interventions. This seamless integration allows for real-time risk assessment without additional data entry, supporting efficient and informed clinical decision-making.

Impact

The CKD Model enables clinicians to provide targeted advice and early treatment to slow CKD progression. This improves the patient’s quality of life and reduces the likelihood of kidney failure and dialysis. At the same time, it assists clinicians in decision-making and treatment planning. Additionally, by prioritising resources for high-risk patients, the model supports more effective population health management.

Future Outlook

The CKD Model is a first step toward using AI to assist in the management of other chronic diseases. Synapxe is actively exploring the application of similar AI prediction models for the proactive care for a range of other chronic conditions.

Resources